We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Will Retain Some Guidances, Allow Others to Expire, After End to COVID Emergency
FDA Will Retain Some Guidances, Allow Others to Expire, After End to COVID Emergency
The FDA has decided the postpandemic fate of 72 final guidances published over the past three years to address COVID-19 issues, choosing to withdraw about one-third, phase out another one-third and retain most of the remainder but plan to update them in the near future.